Belmont, MA, United States of America

Mithra Rothfeder

This inventor holds 1 USPTO granted patent. Top assignee: Novobiotic Pharmaceuticals, LLC. Active years: 2012.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mithra Rothfeder

Introduction

Mithra Rothfeder is an accomplished inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on macrolactam compounds. His innovative approach has led to the development of novel compounds that have the potential to treat various disorders.

Latest Patents

Mithra Rothfeder holds 1 patent for his invention related to macrolactam compounds. This patent encompasses novel macrolactams and their analogs, detailing processes for their preparation, pharmaceutical compositions that include these compounds, and methods for their use in treating or inhibiting various disorders.

Career Highlights

Mithra is currently associated with Novobiotic Pharmaceuticals, LLC, where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, contributing to the creation of effective treatments for a range of health issues.

Collaborations

Mithra collaborates with talented individuals such as Lucy Ling and Qibo Zhang, who contribute to the innovative environment at Novobiotic Pharmaceuticals, LLC. Their teamwork fosters creativity and drives the development of groundbreaking solutions in the pharmaceutical sector.

Conclusion

Mithra Rothfeder's contributions to the field of pharmaceuticals through his innovative work on macrolactam compounds highlight his role as a significant inventor. His ongoing efforts at Novobiotic Pharmaceuticals, LLC, along with his collaborations, continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…